Gourley, Brett L <br/><br/>
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Apr 2010 
 - 1001-4 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-010-1258-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antimetabolites, Antineoplastic--adverse effects<br/>Blood Cell Count<br/>Blood Platelets--metabolism<br/>Creatinine--metabolism<br/>Deoxycytidine--adverse effects<br/>Hemoglobins--metabolism<br/>Hemolytic-Uremic Syndrome--chemically induced<br/>Humans<br/>L-Lactate Dehydrogenase--metabolism<br/>Male<br/>Middle Aged<br/>Purpura, Thrombotic Thrombocytopenic--chemically induced<br/>Rituximab<br/>Gemcitabine